Neurogene Inc. (NGNE) stock forecast and price target
Price $23.93 · data as of November 13, 2026
12-month price target
Average target$77.62
Upside / downside+224.4%
Analysts8
ConsensusStrong buy
Low $46.00Average $77.62High $166.00
Gold marker: average target · white marker: today’s price ($23.93)
Analyst ratings
Strong buy 1Buy 9Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-5.00 | −18.0% | $0 |
| Next fiscal year ends December 31, 2027 | $-4.98 | +0.4% | $0 |
| Next quarter ends December 31, 2026 | $-1.12 | +1.1% | $0 |
| Quarter after ends December 31, 2026 | $-1.18 | −4.7% | $0 |
Consensus of the analysts covering Neurogene, updated daily. In the last 30 days 1 estimates were raised and 3 lowered.
Frequently asked questions
What is the Neurogene stock price target?
The average 12-month target from 8 analysts is $77.62, 224.4% above the current price of $23.93 Targets range from $46.00 to $166.00.
Is Neurogene a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 9 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Neurogene expected to earn?
Analysts expect EPS of $-5.00 for the fiscal year ending December 31, 2026 and $-4.98 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.